Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) Trial of Cardiovascular Events in High-Risk Hypertensive Patients: Rationale, Design, and Methods

Hypertension Research - United Kingdom
doi 10.1291/hypres.26.979
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japanese Society of Hypertension

Related search

Physicians' Attitudes Towards and Reasons for Participation in the Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) Trial

Journal of Epidemiology
MedicineEpidemiology
2005English

Rationale and Design of the KYOTO HEART Study: Effects of Valsartan on Morbidity and Mortality in Uncontrolled Hypertensive Patients With High Risk of Cardiovascular Events

Journal of Human Hypertension
Internal Medicine
2008English

Rationale and Design of a Study to Evaluate Management of Proteinuria in Patients at High Risk for Vascular Events: The IMPROVE Trial

Journal of Human Hypertension
Internal Medicine
2006English

Hypertriglyceridemia Is Associated With Long-Term Risk of Cardiovascular Events and Specific Comorbidity in Very High-Risk Hypertensive Patients

Ukrainian Biochemical Journal
Biochemistry
2020English

Year-Long Antihypertensive Therapy With Candesartan Completely Prevents Development of Cardiovascular Organ Injuries in Spontaneously Hypertensive Rats

International Heart Journal
MedicineCardiovascular MedicineCardiology
2010English

Cardiovascular Risk Assessment in Hypertensive Patients

Revista Latino-Americana de Enfermagem
Nursing
2013English

Pharmacogenomics of Antihypertensive Drugs: Rationale and Design of the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) Study

American Heart Journal
Cardiovascular MedicineCardiology
2009English

Pioglitazone May Reduce Cardiovascular Events in High Risk Patients With Prediabetes

British Medical Journal
Medicine
2016English

Serum Uric Acid and Cardiovascular Events in Successfully Treated Hypertensive Patients

Hypertension
Internal Medicine
1999English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy